Stock futures are little changed after S&P 500 posts fourth consecutive closing record: Live updates

Stock futures are little changed after S&P 500 posts fourth consecutive closing record: Live updates


NEW YORK, NEW YORK – JANUARY 22: Traders work on the floor of the New York Stock Exchange during afternoon trading on January 22, 2024 in New York City. The Dow Jones and S&P both hit all time highs with the Dow Jones closing over 38,000 points for the first time ever as stocks continue to rise.
(Photo by Michael M. Santiago/Getty Images)

Michael M. Santiago | Getty Images News | Getty Images

Stock futures were little changed Thursday, following a fresh record close for the S&P 500 and strong quarterly results from Adobe.

Futures tied to the broad market index slipped 0.1%, while Nasdaq 100 futures ticked up by 0.04%. Dow Jones Industrial Average futures inched down by 0.08%, or 30 points.

In extended trading, software giant Adobe leapt 16% after fiscal second-quarter results surpassed Wall Street estimates. Adobe also raised its full-year guidance, making the company a standout compared to peers in the software space that are citing headwinds tied to macroeconomic trends.

Stocks are coming off a winning session that saw the S&P 500 notch its fourth-straight record close. The technology-heavy Nasdaq Composite also ended the session at a record. Hopes for a continued cooling of inflation have boosted equities this week. The S&P 500 and Nasdaq Composite are on pace to end the week higher. The S&P 500 has climbed 1.6%, while the Nasdaq has added 3.1%. The 30-stock Dow is the lone laggard with a 0.4% decline.

Wholesale inflation unexpectedly ticked down by 0.2% last month, while economists polled by Dow Jones expected the gauge to increase by 0.1%. That follows a consumer price index reading that was flat on a monthly basis in May.

“I think the soft landing is still intact, but I think there’s starting to be and could be jitters about [if] the Fed is staying restrictive for too long,” BD8 Capital Partners CEO Barbara Doran told CNBC’s “Closing Bell: Overtime” on Thursday.

“The market on the surface is expensive at 21 times earnings, but as we know, that’s a handful of stocks [and] if you take that out of the S&P 500, it’s a lot cheaper,” she added. “The question now is breadth.” Market breadth measures the number of stocks that are rising versus those that are falling. When a greater number of stocks are climbing, that suggests a broad uptrend.

Elsewhere, shares of electric vehicle maker Tesla traded marginally higher after the company’s board of directors approved a contentious $56 billion pay package for CEO Elon Musk.



Source

Google joins Microsoft in telling users Anthropic is still available outside defense projects
World

Google joins Microsoft in telling users Anthropic is still available outside defense projects

Google CEO Sundar Pichai gestures to the crowd during Google’s annual I/O developers conference in Mountain View, California, on May 20, 2025. David Paul Morris | Bloomberg | Getty Images Google said it will continue offering Anthropic’s artificial intelligence technology for clients, excluding for defense work, a day after Microsoft issued a similar statement to […]

Read More
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide
World

Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

The U.S. and Israel are showing signs of escalating their war against Iran – a move that could batter a variety of assets, even traditional safe havens. To protect their portfolios, investors can snap up stocks from an oft-shorted sector: pharmaceuticals, UBS analysts say. Since the first strikes last Saturday, the Iran War has roiled […]

Read More
Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’
World

Zealand’s stock falls 35% after disappointing drug result. Its CEO tells CNBC people need to focus less on the ‘weight loss Olympics’

Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight management in adults and adolescents. (Photo by Steve Christo – Corbis/Corbis via Getty Images) Steve Christo – Corbis | Corbis News | Getty Images The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest […]

Read More